stearyl-Nle-VIP

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestearyl-Nle-VIP
Drug Alias Nameimpotence therapy (Senetek)stearyl-norleucine-VIP
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVasoactive intestinal peptide receptor agonists
TargetsVasoactive intestinal peptide receptor
Therapy Area/IndicationsSexual Dysfunction, PhysiologicalAlzheimer DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRamot At Tel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRamot At Tel Aviv UniversitySenetekplc
Active IndicationsN/A
Inactive IndicationsSexual Dysfunction, PhysiologicalAlzheimer DiseaseNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A